SBC Medical Group
SBC | NASDAQ
$5.14
+$0.39 (+8.21%)
At close: Sep 21, 2026, 4:00 PM ET
$5.24
+$0.10 (+1.95%)
Pre-market:
Sep 22, 2026, 4:43 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 175.17M | 169.34M | 173.61M | 178.46M | 188.19M | 197.94M | 205.42M | 223.34M | 217.54M | 205.44M | 193.54M | 131.19M | 83.91M | 42.91M |
Cost of Revenue | 50.33M | 50.46M | 47.03M | 46.94M | 43.34M | 43.67M | 49.37M | 57.8M | 61.73M | 57.13M | 56.24M | 37.26M | 23.48M | 14.4M |
Gross Profit | 124.84M | 118.88M | 126.57M | 131.52M | 144.86M | 154.26M | 156.05M | 165.55M | 155.8M | 148.31M | 137.3M | 93.94M | 60.44M | 28.52M |
Operating Income | 65.41M | 61M | 67.49M | 59.36M | 57.31M | 70.04M | 70.3M | 89.58M | 95.76M | 84.04M | 70.66M | 46.67M | 26.65M | 11.08M |
Interest Income | 249.99K | 264.35K | 198.32K | 198.6K | 86.17K | 74.93K | 37.28K | 37.69K | 39.97K | 28.33K | 68.24K | 67.84K | 57.61K | 57.61K |
Pretax Income | 75.49M | 69.47M | 82.07M | 69.56M | 64.16M | 77.71M | 73.46M | 90.96M | 98.92M | 88.51M | 73.58M | 50.01M | 28.94M | 12.27M |
Net Income | 49.03M | 40.79M | 50.99M | 43.32M | 33.33M | 49.36M | 46.61M | 54.42M | 59.94M | 52.13M | 39.37M | 25.03M | 16.67M | 6M |
Selling & General & Admin | 61.91M | 59.29M | 59.8M | 55.07M | 70.37M | 67.81M | 69.94M | 75.39M | 59.58M | 63.95M | 66.23M | 46.89M | 33.44M | 17.25M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | -2.48M | -1.42M | -710.42K | 17.1M | 17.18M | 16.41M | 15.81M | 580.82K | 457.72K | 317.03K | 409.03K | 380.77K | 352.25K | 192.05K |
Operating Expenses | 59.43M | 57.87M | 59.09M | 72.16M | 87.55M | 84.22M | 85.75M | 75.97M | 60.04M | 64.26M | 66.64M | 47.27M | 33.79M | 17.44M |
Interest Expense | 348.16K | 269.18K | 160.58K | 116.9K | 73.73K | 31.5K | 28.3K | 23.81K | 22.32K | 29.8K | 26.79K | 18.88K | 14.9K | n/a |
Selling & Marketing Expenses | -1.66M | -682.17K | n/a | 3.18M | 3.5M | 3.38M | 3.4M | 2.18M | 1.56M | 711.63K | n/a | n/a | n/a | n/a |
Cost & Expenses | 109.76M | 108.34M | 106.12M | 119.11M | 130.88M | 127.89M | 135.11M | 133.77M | 121.77M | 121.39M | 122.88M | 84.52M | 57.27M | 31.84M |
Income Tax Expense | 25.31M | 28.59M | 31.02M | 26.24M | 30.84M | 28.27M | 26.77M | 36.59M | 39.33M | 37.61M | 35.02M | 25.68M | 12.67M | 5.86M |
Shares Outstanding (Basic) | 102.58M | 102.58M | 102.58M | 102.64M | 103.51M | 103.28M | 102.75M | 95.1M | 94.19M | 94.19M | 94.19M | 94.19M | 9.49M | 15.07M |
Shares Outstanding (Diluted) | 102.58M | 102.58M | 102.58M | 102.64M | 103.51M | 103.28M | 102.75M | 95.1M | 94.19M | 94.19M | 94.19M | 94.19M | 9.49M | 15.07M |
EPS (Basic) | 0.47 | 0.39 | 0.49 | 0.42 | 0.33 | 0.50 | 0.49 | 0.58 | 0.64 | 0.46 | 0.30 | 0.15 | 0.06 | 0.04 |
EPS (Diluted) | 0.47 | 0.39 | 0.49 | 0.42 | 0.33 | 0.50 | 0.49 | 0.58 | 0.64 | 0.46 | 0.30 | 0.15 | 0.06 | 0.04 |
EBITDA | 76.46M | 72.43M | 84.88M | 72.59M | 67.45M | 81.15M | 77.28M | 96.41M | 106.64M | 99M | 85.85M | 59.72M | 35.36M | 15.07M |
EBIT | 74.4M | 69.74M | 82.23M | 69.67M | 64.23M | 77.74M | 73.48M | 90.99M | 98.95M | 88.54M | 73.61M | 50.03M | 28.96M | 12.27M |
Depreciation & Amortization | 2.06M | 2.69M | 2.65M | 2.91M | 3.21M | 3.41M | 3.8M | 5.43M | 7.7M | 10.47M | 12.25M | 9.69M | 6.4M | 2.8M |
Add to Watchlist
Select watchlists to add or remove SBC